National Science Foundation

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Case Western Reserve University, located in Cleveland's University Circle, is an independent research institution established in 1843. It encompasses various schools and colleges, including the School of Medicine, School of Law, Case School of Engineering, College of Arts and Sciences, Frances Payne Bolton School of Nursing, Mandel School of Applied Social Sciences, School of Dental Medicine, and Weatherhead School of Management. The university is known for its excellence in medical education and biomedical research, with the School of Medicine recognized for its contributions to medical discoveries and training future physicians. The School of Law offers nationally ranked programs in international law, health law, and intellectual property law, integrating leadership courses and practical experiences into its curriculum. Case Western Reserve University is a member of the Association of American Universities and maintains full accreditation from the Higher Learning Commission, reflecting its commitment to educational quality and research excellence.

Moshion is a data-driven platform for nurse workflow optimization to address the nursing shortage. We act as another set of eyes to help nurses using our 3D image sensors (100% privacy-preserving) to collect movement data analyzed by our machine learning models. Moshion aims to enter the remote patient monitoring market by focusing on patient turning to prevent pressure injuries. Pressure injuries are wounds that can develop when a patient (often bed bound) stays in the same position. These can be prevented by adhering to turning protocols. Our software tracks that adherence, provides personalized turn schedules for each patient, sends nurses gentle reminders, and auto-documents.

Tiny Cargo specializes in a unique drug delivery system utilizing non-immunogenic bovine milk-derived exosomes. This innovative approach allows for the effective oral or intravenous administration of potent therapeutics. The company focuses on delivering treatments for various serious health conditions, including ischemic heart disease, gastrointestinal radiation disease, and glioblastoma multiforme, among others. By leveraging its technology, Tiny Cargo aims to enhance the delivery of peptide drugs, making it applicable to a wide range of current peptide therapeutics and improving patient outcomes in the treatment of neurological and other pathologies.

JelikaLite specializes in developing medical equipment for children with autism spectrum disorders, focusing on non-invasive methods to enhance brain health. Their primary product is a wearable device that integrates infrared light, EEG sensors, and an artificial intelligence personalization platform. This therapeutic device aims to reduce the symptoms of autism by promoting improvements in speech, decreasing anxiety, and enhancing responsiveness in pediatric patients. By utilizing innovative therapies, JelikaLite seeks to provide lasting benefits for children dealing with autism, emphasizing a commitment to advancing pediatric neurological health.

Oxalo Therapeutics is focused on developing innovative drug therapies aimed at treating rare kidney diseases and preventing recurring kidney stones. The company specifically targets primary hyperoxaluria and other oxalate-related pathologies through a novel approach that utilizes a gut bacterium to facilitate the safe removal of oxalate from the body. By mimicking natural mechanisms, Oxalo Therapeutics seeks to provide effective treatment options for patients suffering from conditions associated with high levels of oxalate, thereby improving their quality of life and reducing the incidence of kidney stone recurrence. The company's expertise in the microbiome and translational research underpins its commitment to advancing early-stage technology in the field of kidney health.

HairDays is an AI-powered health data company that has developed a unique hair intelligence platform focused on simplifying hair classification and care. The platform provides tailored recommendations for maintaining healthy hair, allowing consumers to discover and purchase hair care products suited to their individual needs. By curating relevant content, HairDays enables users to monitor their hair conditions and track their growth progress effectively. This innovative approach eliminates the guesswork often associated with hair care, empowering individuals to make informed decisions about their hair health.

Levisonics is a manufacturer of advanced blood coagulation instruments that specialize in non-contact analysis for blood coagulation and fluid quality control testing. Their products facilitate the assessment of bleeding and thrombosis risks through innovative fluid rheological measurement techniques. In addition to medical applications, Levisonics' technology can be employed in real-time monitoring of the quality of food, liquid, and gel products during production or processing, ensuring safety and compliance in various industries.

Intelligent Medicine specializes in software and simulation services focused on enhancing safety in medical environments through innovative technologies. The company has developed a simulation platform that enables architects and facility stakeholders to evaluate and optimize building designs and operational protocols. By testing various designs and protocols, the platform helps to identify areas for improvement, thereby reducing the likelihood of infectious disease transmission and alleviating user congestion. This capability allows for a rapid feedback loop, supporting the planning and implementation of effective safety policies and design strategies to improve overall outcomes in healthcare settings.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Nanopath Inc. is a molecular diagnostics company focused on enhancing women's health through rapid and precise testing. By utilizing advancements in bioengineering and nanotechnology, the company specializes in the sensitive detection of viral, bacterial, and fungal pathogens without relying on nucleic acid amplification techniques. This innovative approach allows for the delivery of granular and clinically actionable information, thereby improving traditional testing methodologies and enabling healthcare providers to make informed decisions more swiftly.

Averto Medical is a manufacturer of medical devices focused on addressing gastrointestinal diseases. The company specializes in developing innovative solutions designed to facilitate minimally invasive colorectal tumor removal, which aims to reduce the need for multiple surgical procedures and associated complications. By providing effective medical care options for patients suffering from gastrointestinal disorders, Averto Medical seeks to improve patient outcomes and streamline treatment processes in this critical area of healthcare.

CorInnova Incorporated provides device-based therapies for the treatment of congestive heart failure. CorInnova’s non-blood-contacting soft robotic cardiac assist device could potentially triple or quadruple the number of heart failure patients who could be eligible for such a life-saving device therapy.”

Pragma Health provides digital healthcare services. They permit users to perform different tests for cardiovascular, hematology, infectious diseases, and others in the privacy of their home and provide accurate, immediate results, enabling them to get a convenient, cost-effective, and accurate healthcare testing process.

NeuroTechR3 is a biomedical device and digital health start-up that focuses on developing affordable rehabilitation technologies to enhance upper extremity function for individuals affected by brain injuries, including stroke and cerebral palsy. The company's flagship innovation, R3THATM, leverages machine learning and cloud technology to enable personalized telerehabilitation through engaging exergames designed to foster neuroplasticity. This system includes features such as motion tracking, analytics, and real-time biofeedback, which help clinicians provide high-quality, efficient care while improving patient recovery outcomes. Founded in 2020 by a team of four women, NeuroTechR3 emerged from the New Jersey Institute of Technology and Rutgers University, and operates from locations in Newark, NJ, and Philadelphia, PA. The company's expertise lies in biomedical engineering and computer science, positioning it to address the needs of the rehabilitation industry effectively. By advancing rehabilitation devices and machine learning-driven technologies, NeuroTechR3 aims to transform healthcare and make rehabilitation more accessible and sustainable for individuals with various impairments.

Access Airways provides intubation-delivering devices that reduce risk and win confidence in clinicians and patients. They designed it to provide safer, quicker, and less harmful procedures with its intuitive capabilities and added functionality. They improve the time to intubate and reduce failed intubation attempts.

PolyLux is an advanced materials company that develops light-switchable adhesive platforms. The company was founded in 2016 and is headquartered in Akron, Ohio.

CellDrop Biosciences develops hydrogel-based point-of-care diagnostics and targeted biomaterial delivery technology. The company was established in 2017 and is headquartered in Laramie, Wyoming.

Carrisan Technologies is a food technology company that develops novel antimicrobial solutions. The company was founded in 2019 and is based in Davis, California.

NeuroTechR3 is a biomedical device and digital health start-up that focuses on developing affordable rehabilitation technologies to enhance upper extremity function for individuals affected by brain injuries, including stroke and cerebral palsy. The company's flagship innovation, R3THATM, leverages machine learning and cloud technology to enable personalized telerehabilitation through engaging exergames designed to foster neuroplasticity. This system includes features such as motion tracking, analytics, and real-time biofeedback, which help clinicians provide high-quality, efficient care while improving patient recovery outcomes. Founded in 2020 by a team of four women, NeuroTechR3 emerged from the New Jersey Institute of Technology and Rutgers University, and operates from locations in Newark, NJ, and Philadelphia, PA. The company's expertise lies in biomedical engineering and computer science, positioning it to address the needs of the rehabilitation industry effectively. By advancing rehabilitation devices and machine learning-driven technologies, NeuroTechR3 aims to transform healthcare and make rehabilitation more accessible and sustainable for individuals with various impairments.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Oncospace, Inc. is a medical technology company founded in 2018 and based in Baltimore, Maryland, specializing in personalized medicine for radiation oncology. It has developed an AI-powered platform that leverages clinical treatment data to create optimized treatment plans tailored to individual patients. This platform aims to enhance patient outcomes by minimizing side effects and improving the overall quality of life. Through the use of machine learning, Oncospace's technology establishes best-practice dosimetric goals, facilitating better planning and evaluation in radiation therapy. The company focuses on fostering collaborative relationships within the medical community, thereby advancing the field of radiation oncology.

Proov offers patented at home testing systems - including the only FDA cleared at-home test to measure progesterone metabolite PdG - to help women understand and act on their hormones. When used with the Proov Insight app, Proov's easy, at-home pee tests provide a science-backed fertility coach right in your hand. First, a woman can measure all of the menstrual hormones daily with Proov tests, then snap a photo of each test within the Insight app. Then, a woman can follow the in-app prompts throughout her cycle to understand ovulation status, get daily insights and an Ovulation Insights score. Finally, the app generates a personalized action plan to maximize her wellness or develop a fertility strategy. Proov was founded by Amy Beckley, Ph.D, the "infertile scientist," after three years of infertility and seven miscarriages. Amy applied her own science expertise to uncover a luteal phase defect (a problem with ovulation quality). With help from her doctor and a simple supplement, Amy was able to get pregnant with her daughter. Proov is a venture capital backed company and the leader in understanding hormone health on the basis of tracking PdG, a metabolite of progesterone.

HabitAware manufactures and distributes wearable devices that assists its users with minimizing trichotillomania. The devices use motion sensors to assist its users with minimizing repetitive habits, including nail biting, hair pulling, skin picking, and thumb sucking by providing it with training. It features Bluetooth connectivity and customizable vibration patterns. HabitAware was founded in 2014 and is based in Minneapolis.

Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders. Plexision's first patented product, the PleximmuneTM assay, predicts the risk of transplant rejection. The test is based on patent-pending technology to measure antigen-specific white blood cells. Testing services for transplant recipients and drug developers are provided at Plexision’s CLIA-certified, central laboratory in Pittsburgh. Plexision currently offers cell-based testing for personalized assessment of rejection risk after solid organ transplantation The Pleximmune blood test is the first such test offered for children with liver or intestine transplantation.

Travera, LLC is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. It specializes in a unique measurement technology that utilizes the Suspended Microchannel Resonator (SMR), a MEMS device capable of detecting minute changes in the weight of individual cancer cells. This technology focuses on the Mass Accumulation Rate (MAR) biomarker, which indicates how cancer cells respond to various drugs within hours of exposure. By measuring these rapid changes, Travera enables oncologists to make informed decisions about which therapies to prescribe based on the actual responses of a patient’s tumor cells. This approach aims to enhance the effectiveness of cancer treatment by distinguishing between natural cell death and drug-induced cell death, thereby improving patient outcomes.

EnVision Endoscopy specializes in developing medical devices for endoscopic surgeries, focusing on enhancing clinical outcomes for patients and efficiency for healthcare providers. The company's flagship product is an image-guided suturing system that attaches to standard flexible endoscopes, facilitating tissue approximation during surgical procedures. This biodegradable, single-use device simplifies various surgical tasks, making it more accessible for gastroenterologists and surgeons. By streamlining procedures, EnVision Endoscopy aims to reduce both procedure times and associated mortality rates, thereby improving overall patient care in the medical field.

Manus Robotics is focused on developing a smart health and wellness device aimed at promoting independent and healthy living. The company offers a wearable robot that assists individuals with disabilities in their daily activities, providing intelligent support to enhance their quality of life. In addition to daily living assistance, the device collects and analyzes muscle data from patients, facilitating rehabilitation efforts and helping users regain independence.

Biocogniv Inc. specializes in developing artificial intelligence-powered diagnostic tools designed for hospitals, with a focus on enhancing clinical operations. Founded in 2019 and based in Burlington, Vermont, the company provides plugins for electronic health record (EHR) systems that enable real-time screening of patients for conditions such as COVID-19 by analyzing standard blood test results. Biocogniv's platform is particularly beneficial for emergency departments, as it can predict sepsis-related mortality and the need for intensive care unit admission. By leveraging the vast amounts of clinical and administrative data generated by hospitals, Biocogniv aims to improve the quality, cost, and accessibility of healthcare while facilitating accurate and non-invasive diagnostic methods.

3i DIAGNOSTICS provides technology that enables physicians to identify infectious microbes in less than minutes while leaving them intact for further testing. They help to make more informed infection-treatment decisions while practising antibiotic stewardship.

Unlocked Labs specializes in developing innovative probiotics aimed at addressing chronic health conditions by utilizing genetically optimized microbial strains. The company focuses on activating dormant microbial abilities to effectively digest compounds that can lead to health issues. Their first product targets the risk of kidney stones by breaking down stone-forming compounds derived from healthy foods like leafy vegetables. Unlocked Labs employs alternative regulatory pathways to expedite the availability of safe and effective probiotic solutions for consumers. By harnessing the natural detoxifying capabilities of symbiotic microbes, their products aim to reduce acid levels in the body, making them both affordable and accessible to a wide audience.

Hubly Surgical Inc. is a medical technology company focused on enhancing patient outcomes and improving the quality of care in neurosurgery. Founded in 2018 and based in San Francisco, California, with an additional office in Chicago, the company has developed an integrated electric drill system that replaces traditional free-hand techniques. This innovative device aims to reduce the rate of lethal complications associated with surgical drilling and is designed to facilitate bedside intracranial access, decreasing the reliance on operating rooms. Hubly's mission is to make its safety technology the standard of care for medical drilling, ensuring that both standard and underserved settings can benefit from improved surgical procedures.

AxonDx is a company focused on the detection of circulating tumor cells (CTCs) in blood samples, which serve as a crucial indicator of both primary tumors and potential metastases. Their innovative nCYTE™ technology allows for the rapid scanning of un-enriched blood samples, identifying all classes of CTCs shed by solid tumors within minutes. This method not only enhances the accuracy of detection but also provides detailed morphological and molecular characterization of the identified cells. By enabling faster and more comprehensive insights into a patient’s cancer status, AxonDx's solutions support personalized medical treatment and early cancer detection. The company operates on a “razor and blade” business model, selling nCYTE™ instruments and associated diagnostic kits, making their technology accessible at the point of care. This advancement represents a significant improvement over existing CTC detection methods, which are often slow, costly, and less sensitive.

Averto Medical is a manufacturer of medical devices focused on addressing gastrointestinal diseases. The company specializes in developing innovative solutions designed to facilitate minimally invasive colorectal tumor removal, which aims to reduce the need for multiple surgical procedures and associated complications. By providing effective medical care options for patients suffering from gastrointestinal disorders, Averto Medical seeks to improve patient outcomes and streamline treatment processes in this critical area of healthcare.

HabitAware manufactures and distributes wearable devices that assists its users with minimizing trichotillomania. The devices use motion sensors to assist its users with minimizing repetitive habits, including nail biting, hair pulling, skin picking, and thumb sucking by providing it with training. It features Bluetooth connectivity and customizable vibration patterns. HabitAware was founded in 2014 and is based in Minneapolis.

AnkyrBio is a biotechnology company focused on commercializing its proprietary anchoring system. The company is based in Pittsburgh, Pennsylvania.

TAO Connect, Inc. offers an online treatment program designed to address various mental health issues, including generalized anxiety, social anxiety, performance anxiety, panic, and more. The company's cognitive behavioral treatment module enables patients to actively engage in behavioral change while allowing clinicians to monitor progress and symptom changes over time. This module features online educational resources, video conferencing, text messaging, push notifications, and daily practice assignments accessible via smartphones. Additionally, TAO Connect provides treatments for substance abuse recovery, mindfulness, depression, and trauma, as well as training for its treatment modules. The services are utilized by a diverse range of organizations, including college counseling centers, wellness centers, employee assistance programs, outpatient clinics, VA medical centers, and private practitioners. Founded in 2014 and based in Saint Petersburg, Florida, TAO Connect is dedicated to making mental health treatment more affordable and accessible, particularly for individuals who have historically faced barriers to care.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Oxalo Therapeutics is focused on developing innovative drug therapies aimed at treating rare kidney diseases and preventing recurring kidney stones. The company specifically targets primary hyperoxaluria and other oxalate-related pathologies through a novel approach that utilizes a gut bacterium to facilitate the safe removal of oxalate from the body. By mimicking natural mechanisms, Oxalo Therapeutics seeks to provide effective treatment options for patients suffering from conditions associated with high levels of oxalate, thereby improving their quality of life and reducing the incidence of kidney stone recurrence. The company's expertise in the microbiome and translational research underpins its commitment to advancing early-stage technology in the field of kidney health.

Oncospace, Inc. is a medical technology company founded in 2018 and based in Baltimore, Maryland, specializing in personalized medicine for radiation oncology. It has developed an AI-powered platform that leverages clinical treatment data to create optimized treatment plans tailored to individual patients. This platform aims to enhance patient outcomes by minimizing side effects and improving the overall quality of life. Through the use of machine learning, Oncospace's technology establishes best-practice dosimetric goals, facilitating better planning and evaluation in radiation therapy. The company focuses on fostering collaborative relationships within the medical community, thereby advancing the field of radiation oncology.

EnVision Endoscopy specializes in developing medical devices for endoscopic surgeries, focusing on enhancing clinical outcomes for patients and efficiency for healthcare providers. The company's flagship product is an image-guided suturing system that attaches to standard flexible endoscopes, facilitating tissue approximation during surgical procedures. This biodegradable, single-use device simplifies various surgical tasks, making it more accessible for gastroenterologists and surgeons. By streamlining procedures, EnVision Endoscopy aims to reduce both procedure times and associated mortality rates, thereby improving overall patient care in the medical field.

Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Travera, LLC is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. It specializes in a unique measurement technology that utilizes the Suspended Microchannel Resonator (SMR), a MEMS device capable of detecting minute changes in the weight of individual cancer cells. This technology focuses on the Mass Accumulation Rate (MAR) biomarker, which indicates how cancer cells respond to various drugs within hours of exposure. By measuring these rapid changes, Travera enables oncologists to make informed decisions about which therapies to prescribe based on the actual responses of a patient’s tumor cells. This approach aims to enhance the effectiveness of cancer treatment by distinguishing between natural cell death and drug-induced cell death, thereby improving patient outcomes.

Cybele Microbiome is a company focused on enhancing skin health through precision control of the microbiome. Utilizing a proprietary AI platform that integrates machine learning with advanced biotechnology, Cybele Microbiome develops customized skincare products aimed at improving the skin's natural barrier. The company's approach includes genetic sequencing methods and the use of sustainable nutrient sources to create targeted natural solutions that support the microbiome. By leveraging AI tools and microbiome science, Cybele Microbiome seeks to revolutionize skincare, enabling customers to maintain skin integrity while promoting overall health and longevity.

Rumi Scientific is a research-oriented company focused on developing innovative medications and treatments for genetic disorders affecting the central nervous system, particularly Huntington's Disease. The company utilizes a proprietary human organoid platform that simulates human development in vitro, integrating gene editing techniques with multi-cellular self-organization to create defined diseased embryonic tissues. This advanced platform facilitates drug discovery and high-throughput screening, leveraging artificial intelligence to identify potential treatments. By emphasizing synthetic human embryology in both healthy and diseased contexts, Rumi Scientific aims to advance therapeutic options for numerous genetic conditions that currently lack effective cures. The company's approach combines single-cell, time-lapse imaging with customized analytic tools, resulting in a more efficient and cost-effective drug development process that enhances treatment success rates and outcomes for patients.

Welcome to The University of Vermont Health Network, five partner hospitals serving the residents of Vermont and northern New York. With over 4,000 health care providers throughout our region, they work together to offer high-quality care more cost-efficiently and as close to home as possible. Strengthened by their connection, each of their hospitals remains committed to its local community and to the heart and science of medicine: compassionate, personal care shaped by the latest medical advances and delivered by highly skilled experts.

PolyLux is an advanced materials company that develops light-switchable adhesive platforms. The company was founded in 2016 and is headquartered in Akron, Ohio.

3i DIAGNOSTICS provides technology that enables physicians to identify infectious microbes in less than minutes while leaving them intact for further testing. They help to make more informed infection-treatment decisions while practising antibiotic stewardship.

Norwich University, a small New England college located in Northfield, Vermont, is the home of the ROTC and offers the full range of academic and professional programs to cadets and others. The ROTC program, which trains cadets, is one of Norwich’s more noteworthy academic offerings. However, non-cadets also attend to take advantage of undergraduate liberal arts and science degrees as well as professional majors in Architecture, Computer Science, Engineering, Pre-Law and Pre-Medicine. Graduate degrees at Norwich are delivered through online study. Online master’s degrees are awarded in such fields as Diplomacy, Education, Military History, Civil Engineering, Public Administration and Nursing. Based in the experiential learning model, Norwich’s curriculum uses a combination of experiential and theoretical techniques, a highly effective strategy for long-term integration of knowledge. Since it is an ROTC-friendly school, there are several benefits financially and otherwise for current and former military. Other financial aid options include loans, grants and scholarships for those who qualify. Applicants will need to submit an application, a personal statement, a transcript, and test scores to the admissions department. Letters of recommendation are also strongly suggested.

MyHomecareBiz specializes in developing intuitive software solutions for the home health care industry, focusing on automating essential processes such as patient care, billing, scheduling, and physician orders. Established in 1998, the company’s software is crafted with the input of home health care professionals, ensuring that it meets the practical needs of nurses and therapists. Key products include SmartDX, a mobile application that tracks Value-Based Purchasing outcomes and facilitates real-time updates to care plans, and TurboClaim, an efficient billing system that streamlines the claims process by automatically scrubbing and submitting claims while managing payment postings. This allows health care providers to concentrate on delivering quality patient care rather than dealing with administrative tasks.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

DFusion is a science-based behavioral health research and development company that focuses on promoting behavior change for health, prevention, and adherence. Leveraging evidence-based models and learning theories, DFusion creates innovative applications of both modern and traditional technologies aimed at enhancing health outcomes. The company develops smartphone, tablet, and web applications that are informed by behavioral research, ensuring an optimal user experience. Additionally, DFusion offers consultation services and professional development opportunities within the health and education sectors. Their team, comprised of scientists and innovators, is dedicated to challenging existing paradigms and improving the health and well-being of individuals throughout their lifespans. DFusion operates from offices in Scotts Valley and Oakland, California.

Teaching It Right is an educational curriculum development company focused on serving children diagnosed with autism spectrum disorder. The company creates supplementary materials and curricula tailored for individuals and educational institutions, as well as professionals involved in autism education. Their offerings include an integrated mobile application designed to teach social skills and a multi-sensory therapy program aimed at enhancing eye contact. These services are intended to help children engage more fully in society, prepare for self-sufficiency, and improve their future employment opportunities.

CrossLife Technologies is a life science firm that creates and sells molecular diagnostics for infectious diseases and non-communicable diseases with the objective of decreasing suffering and enhancing health. They are finding, creating, and commercializing genetic material diagnostic tools.

Shasqi, Inc. is a biopharmaceutical company based in San Francisco, California, founded in 2018. It specializes in the development of a unique platform known as CAPAC (Click Activated Protodrugs Against Cancer), which utilizes click chemistry for localized drug activation. This innovative approach allows for the activation of chemotherapeutic agents directly at tumor sites, thereby concentrating the drug's effects where they are most needed while minimizing systemic toxicity. The technology involves injecting a polymer gel that contains a click chemistry reagent in the tumor area, which subsequently activates a systemically administered protodrug when they interact. Shasqi's platform has demonstrated efficacy in human trials, indicating its potential to enhance cancer treatment outcomes and paving the way for future advancements in click-chemistry-based therapies.

Workit Health, Inc. is a provider of online therapeutic content and professional counseling services focused on substance use recovery. Established in 2014 and based in Ann Arbor, Michigan, the company operates the Workit platform, which offers clinically proven telemedicine treatment for substance use disorder, including online therapy, medication-assisted treatment, psychiatric support, and primary care. Workit Health's services are designed to help individuals achieve long-term recovery from drugs and alcohol while minimizing disruption to their daily lives. The platform facilitates access to on-demand, in-person, and virtual medical and psychosocial support, catering to a wide range of clients including employers, educational institutions, healthcare facilities, and recovery communities. Additionally, Workit Health provides accredited opioid addiction treatment featuring buprenorphine, enhancing its commitment to harm reduction in addiction care. The company has locations in California, New Jersey, Alaska, and Washington.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

iotaMotion, Inc. is a company based in Iowa City, Iowa, that specializes in the development and manufacture of cochlear ear implants aimed at treating hearing loss. Founded in 2015, the company has created a robotic-assisted surgical system designed to standardize the insertion of cochlear implant electrodes. This innovative technology enhances surgical precision by controlling the speed and acceleration of electrode insertion, which helps to reduce variability in surgical procedures. By personalizing the approach to each patient, iotaMotion enables surgeons to provide more accurate and tailored cochlear interventions, ultimately expanding access to these critical treatments for both patients and healthcare providers.

At Triton Algae Innovations we provide novel solutions for the world’s food and feed shortages and have taken the microalgae, Chlamydomonas reinhardtii, through the GRAS process. Chlamydomonas is safe, tastes great and is rich in essential amino acids, omega-3 fatty acids, vitamin A and other vital nutrients. To unleash Chlamydomonas’ potential, Triton developed scalable, environment-friendly manufacturing processes, demonstrated benefits to gut health, and pioneered biotechnology tools to produce nutritional compounds, such as colostrum proteins, for future foods

AbiliLife is a company dedicated to designing and developing products to improve the quality of life for patients with Parkinson's and other neurodegenerative diseases.

Shasqi, Inc. is a biopharmaceutical company based in San Francisco, California, founded in 2018. It specializes in the development of a unique platform known as CAPAC (Click Activated Protodrugs Against Cancer), which utilizes click chemistry for localized drug activation. This innovative approach allows for the activation of chemotherapeutic agents directly at tumor sites, thereby concentrating the drug's effects where they are most needed while minimizing systemic toxicity. The technology involves injecting a polymer gel that contains a click chemistry reagent in the tumor area, which subsequently activates a systemically administered protodrug when they interact. Shasqi's platform has demonstrated efficacy in human trials, indicating its potential to enhance cancer treatment outcomes and paving the way for future advancements in click-chemistry-based therapies.

Digidence develops software tools for oncology departments and practices of patient outcomes. They offer a range of services, including data collecting and analysis, interventional studies, pragmatic studies, patient-centered research, outcomes research, patient-reported outcomes, pharmaceuticals, life sciences, and software development.

Cardiio is a digital health company that emerged from MIT, specializing in the development of intelligent algorithms that utilize smartphones and wearables for health monitoring. The company focuses on creating software applications that transform smartphone cameras into biosensors, enabling users to measure their heart rates accurately. Their flagship product, the Cardiio Heart Rate Monitor, is a mobile app that allows individuals to track their heart rate for general wellness and fitness purposes. By leveraging machine learning, Cardiio aims to enhance the monitoring of wellness, fitness, and chronic diseases, making health management more accessible and efficient for users.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

At Triton Algae Innovations we provide novel solutions for the world’s food and feed shortages and have taken the microalgae, Chlamydomonas reinhardtii, through the GRAS process. Chlamydomonas is safe, tastes great and is rich in essential amino acids, omega-3 fatty acids, vitamin A and other vital nutrients. To unleash Chlamydomonas’ potential, Triton developed scalable, environment-friendly manufacturing processes, demonstrated benefits to gut health, and pioneered biotechnology tools to produce nutritional compounds, such as colostrum proteins, for future foods

CREmedical, founded in 2011 and headquartered in Kingston, Rhode Island, specializes in the development of electroencephalography equipment aimed at enhancing the understanding of brain function and aiding in the diagnosis and treatment of mental illnesses and brain disorders. The company's innovative devices monitor brainwaves and are designed to facilitate the recording of electroencephalograms (EEGs) in home settings. This technology not only assists healthcare professionals in detecting life-threatening events but also has the potential to prevent seizures, thereby improving patient care and outcomes.

Digidence develops software tools for oncology departments and practices of patient outcomes. They offer a range of services, including data collecting and analysis, interventional studies, pragmatic studies, patient-centered research, outcomes research, patient-reported outcomes, pharmaceuticals, life sciences, and software development.

Gliimpse is a health record management platform that aims to empower individuals to manage and share their personal health data securely. By addressing the challenges of fragmented medical records, Gliimpse aggregates data from various sources into a cohesive, patient-owned health profile. This platform allows users to track their medical history, access information from multiple patient portals, and include their own health data, facilitating a comprehensive overview of their health. Ultimately, Gliimpse provides a means for patients to take control of their health records and share them with trusted parties, enhancing the management of personal health information.

Solinas Medical is a medical device company focused on enhancing vascular access technology for hemodialysis. The company aims to improve patient outcomes by addressing complications associated with cannulation, which can lead to leakage and other issues during treatment. By developing a specialized patch designed for these challenges, Solinas Medical enables healthcare professionals to perform procedures more effectively, ultimately improving the quality of life for hemodialysis patients. In addition to enhancing patient care, their innovations also contribute to reducing overall healthcare costs associated with complications in vascular access procedures.

MedShape is a privately held medical device company founded in 2005 based on a portfolio of proprietary surgical solutions that use its patented adaptive shape memory healing technologies to address the increasing demand for improved joint fusion, sports medicine, and musculoskeletal trauma products. MedShape® has enjoyed long-term support from Hills Capital Management, the Georgia Research Alliance (GRA), the National Science Foundation (NSF), the National Institutes of Health (NIH), and In-Q-Tel.

Sheepdog Sciences offers learning services for individuals diagnosed with attention deficit hyperactivity. Sheepdog Sciences was founded in 2011 by Daniel Wetmore and Alexander Butterwick and is based in California.

CREmedical, founded in 2011 and headquartered in Kingston, Rhode Island, specializes in the development of electroencephalography equipment aimed at enhancing the understanding of brain function and aiding in the diagnosis and treatment of mental illnesses and brain disorders. The company's innovative devices monitor brainwaves and are designed to facilitate the recording of electroencephalograms (EEGs) in home settings. This technology not only assists healthcare professionals in detecting life-threatening events but also has the potential to prevent seizures, thereby improving patient care and outcomes.

CardioWise, Inc. is a company focused on developing and commercializing heart analysis software that enhances the evaluation of cardiac health. Founded in 2010 and based in Fayetteville, Arkansas, CardioWise offers a non-invasive cardiac CT analysis software known as SQuEEZ, which generates a quantified 4D image model of the human heart. This software allows for a quantitative diagnostic assessment of the heart by utilizing high-resolution cardiac CT scan data acquired in a single heartbeat. By leveraging cloud-based technology, CardioWise provides cardiologists and patients with easy-to-interpret 3D color maps of heart function accessible from any mobile device through a secure portal. The company's goal is to simplify the diagnosis of heart disease, improve standards of cardiac care, and reduce healthcare costs globally, while also increasing the accuracy of diagnoses and enabling timely interventions.

EnGen Bio is a development-stage biotechnology company that pioneers a new approach to preventing and treating influenza. It believes that it has identified a candidate Universal Type A Influenza vaccine. Influenza drugs and vaccines are unique because there is sufficient government funding available to develop these assets well into human clinical trials, and possibly to market. EnGen Bio is aggressively pursuing this and similar opportunities. It is founded in 2017 and is headquartered in Redwood City, California.

GigaGen, Inc. is a biopharmaceutical company focused on developing innovative antibody therapies for cancer and immune deficiencies. Founded in 2010 and based in South San Francisco, California, GigaGen employs advanced technologies such as microfluidics, bioinformatics, sequencing, and genetic engineering to analyze B and T cell repertoires. This enables the identification of full-length, natively paired antibodies and T cell receptors. The company is advancing a pipeline that includes novel oncology antibody drug combinations and the first recombinant polyclonal hyperimmune gammaglobulin. GigaGen's proprietary discovery technology allows for the rapid characterization of cells within complex immune systems, which facilitates the selection of drug targets and the identification of potential drug candidates, ultimately enhancing preclinical efficacy assessments.

GenEndeavor is a biotechnology firm that creates platforms for the next generation of molecular technology to enable quick and accurate identification of infectious and genetic illnesses in real time at the point of presentation. Its objective is to increase access to extremely early genetic and infectious illness screening. They aim to identify diseases while they are still curable by lowering the detection limit of uncommon mutations and infections. Its assay technology platforms will make point-of-care testing sensitive, quick, and economical.